English
español
English
français
español
English
français
Recent submissions
DIGIBUG Home
1.-Investigación
Departamentos, Grupos de Investigación e Institutos
Departamento de Biología Celular
Recent submissions
DIGIBUG Home
1.-Investigación
Departamentos, Grupos de Investigación e Institutos
Departamento de Biología Celular
Recent submissions
Toggle navigation
JavaScript is disabled for your browser. Some features of this site may not work without it.
Departamento de Biología Celular: Recent submissions
Now showing items 6-10 of 60
Insight into the biological pathways underlying fibromyalgia by a proteomic approach
Ramírez-Tejero, Jorge Antolín
;
Martínez-Lara, Esther
;
Rus Martínez, María del Alma
;
Camacho, Mª Victoria
;
Del Moral, Mª Luisa
; [et al.]
(
2018-07-17
)
Predictive Ability of Serum Amino Acid Levels to Differentiate Fibromyalgia Patients from Healthy Subjects
Rus Martínez, María del Alma
;
López-Sánchez, José Alberto
;
Martínez-Martos, José Manuel
;
Ramírez-Expósito, Mª Jesús
;
Molina, Francisco
; [et al.]
(
2023-10-16
)
Microscopy-based siRNA screen of microglia to identify neuroprotective drug targets
Neubrand, Veronika Elisabeth
;
Delgado, Mario
(
2017
)
The DNA-methyltransferase inhibitors zebularine and decitabine induce mitochondria-mediated apoptosis and DNA damage in p53 mutant leukemic T cells
Ruiz Magaña, María José
;
Saldivia, Manuel A.
;
Morales, Jorge C.
;
Rodríguez-Vargas, José Manuel
;
Schulze-Osthoff, Klaus
; [et al.]
(
2012-03-01
)
Regulation of the resistance to TRAIL-induced apoptosis in human primary T lymphocytes: role of NF-kappaB inhibition
Morales, Jorge C.
;
Ruiz Magaña, María José
;
Ruiz Ruiz, Carmen
(
2007-04
)
Search DIGIBUG
This Community
My Account
Login
Register
Browse
All of DIGIBUG
Communities and Collections
By Issue Date
Authors
Titles
Subject
Financiación
Author profiles
This Community
By Issue Date
Authors
Titles
Subject
Financiación
Servicios
Pasos para autoarchivo
Ayuda
Licencias Creative Commons
SHERPA/RoMEO
Dulcinea
Biblioteca Universitaria
Nos puedes encontrar a través de
Condiciones legales